Advertisement
Singapore markets closed
  • Straits Times Index

    3,313.48
    +8.49 (+0.26%)
     
  • Nikkei

    38,787.38
    -132.88 (-0.34%)
     
  • Hang Seng

    19,553.61
    +177.08 (+0.91%)
     
  • FTSE 100

    8,420.26
    -18.39 (-0.22%)
     
  • Bitcoin USD

    67,097.81
    +236.30 (+0.35%)
     
  • CMC Crypto 200

    1,364.42
    -9.42 (-0.69%)
     
  • S&P 500

    5,303.27
    +6.17 (+0.12%)
     
  • Dow

    40,003.59
    +134.21 (+0.34%)
     
  • Nasdaq

    16,685.97
    -12.35 (-0.07%)
     
  • Gold

    2,419.80
    +34.30 (+1.44%)
     
  • Crude Oil

    80.00
    +0.77 (+0.97%)
     
  • 10-Yr Bond

    4.4200
    +0.0430 (+0.98%)
     
  • FTSE Bursa Malaysia

    1,616.62
    +5.51 (+0.34%)
     
  • Jakarta Composite Index

    7,317.24
    +70.54 (+0.97%)
     
  • PSE Index

    6,618.69
    -9.51 (-0.14%)
     

Compared to Estimates, Cigna (CI) Q1 Earnings: A Look at Key Metrics

For the quarter ended March 2024, Cigna (CI) reported revenue of $57.25 billion, up 23.2% over the same period last year. EPS came in at $6.47, compared to $5.41 in the year-ago quarter.

The reported revenue represents a surprise of +1.07% over the Zacks Consensus Estimate of $56.64 billion. With the consensus EPS estimate being $6.17, the EPS surprise was +4.86%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

ADVERTISEMENT

Here is how Cigna performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Medical Care Ratio - Cigna Healthcare: 79.9% compared to the 81.9% average estimate based on seven analysts.

  • Covered Lives By Funding Type - Medical Customers - Total U.S. Commercial insured: 3,947 thousand compared to the 2,657.56 thousand average estimate based on five analysts.

  • Covered Lives By Market Segment - Medical Customers - International Health: 1,622 thousand compared to the 1,463.29 thousand average estimate based on five analysts.

  • Covered Lives By Market Segment - Medical Customers - U.S. Commercial - Total: 17,562 thousand versus 16,087.65 thousand estimated by four analysts on average.

  • Revenues- Evernorth Health Services: $46.23 billion compared to the $45.58 billion average estimate based on six analysts. The reported number represents a change of +27.8% year over year.

  • Revenues- Evernorth Health Services- Pharmacy: $43.17 billion versus the six-analyst average estimate of $42.66 billion. The reported number represents a year-over-year change of +28.3%.

  • Revenues- Cigna Healthcare- Premiums: $11.53 billion compared to the $11.39 billion average estimate based on six analysts. The reported number represents a change of +5.5% year over year.

  • Revenues- Cigna Healthcare- Premiums- U.S. Government - Medicare Advantage: $2.29 billion compared to the $2.27 billion average estimate based on five analysts. The reported number represents a change of +2.3% year over year.

  • Revenues- Cigna Healthcare- Premiums- U.S. Government - Other: $1.26 billion compared to the $1.41 billion average estimate based on five analysts. The reported number represents a change of -18.4% year over year.

  • Services (Fees)- Cigna Healthcare: $1.57 billion versus $1.78 billion estimated by five analysts on average.

  • Revenues- Pharmacy: $42.04 billion versus $41.63 billion estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +30.8% change.

  • Revenues- Cigna Healthcare- Premiums- U.S. Commercial - Stop loss: $1.67 billion versus the five-analyst average estimate of $1.65 billion. The reported number represents a year-over-year change of +11%.

View all Key Company Metrics for Cigna here>>>

Shares of Cigna have returned -1.1% over the past month versus the Zacks S&P 500 composite's -4.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Cigna Group (CI) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research